Robert Falconer

Mr. Robert Falconer


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2025 in Biofilm
Verified
Journal Article
Open access
RFRobert Falconer
Robert Falconer
TSTyler Smith
Tyler Smith
DRDavid Rothberg
David Rothberg
JGJeremy Gililland
Jeremy Gililland
NANicholas Ashton
Nicholas Ashton
DWDustin Williams
Dustin Williams
Wound irrigation is routinely performed as part of the DAIR procedure and for hardware infections, yet the most effective irrigation solution for reducing bacterial bioburden is unknown. Clinicians can choose on-label, commercially available irrigation solutions or hand-mix preparations off-label on the operating back table. Current methods for evaluating antiseptic efficacy often do not represent the clinical scenario. Here, we present a proof-of-concept ex vivo setup to evaluate whether on-label, commercially available irrigation solutions were superior at reducing bacterial biofilm burden compared to off-label, hand-mixed irrigation solutions. Staphylococcus aureus ATCC 49525 (Xen36) biofilms were grown on Grade 5 titanium simulated fracture fixation plates and secured to sections of autoclaved bovine femur with cortical bone screws. Fourteen irrigation solutions (three commercial, eleven hand-mixed) and one untreated control group were evaluated by irrigating the biofilm-ridden plates and quantifying the remaining bioburden using a 10-fold dilution series to determine the log10 reduction. None of the fourteen treatments reduced bioburden statistically significantly compared to the untreated control, where no irrigation was performed. Additionally, no treatment achieved the FDA benchmark of a 4 log10 reduction for antibacterial activity. An off-label, hand-mixed 0.472 % w/v chlorhexidine gluconate solution reduced the greatest bioburden overall, with a 1.43 ± 0.20 log10 reduction. On-label irrigation products did not reduce bioburden more than off-label, hand-mixed solutions clinicians often prepare in the operating room. Musculoskeletal infections remain a significant clinical challenge and contribute to increasing healthcare costs. The antimicrobial efficacy of irrigation products should be assessed using clinically relevant models.

2 December 2025 in Journal of Bone and Joint Infection
Verified
Journal Article
Open access
PDF file
RFRobert Falconer
Robert Falconer
DRDavid Rothberg
David Rothberg
WKWalker Kay
Walker Kay
CHConnor Hunt
Connor Hunt
RERichard T Epperson
Richard T Epperson
DWDustin Williams
Dustin Williams
Introduction: Infection remains a major complication of open fractures, with rates reaching up to 70 % after severe injury. Systemic antibiotics often fail to achieve the therapeutic levels needed to disrupt biofilm at the wound site due to compromised blood flow and systemic dilution. This study investigates the efficacy of systemic antibiotics against Staphylococcus aureus and Pseudomonas aeruginosa monomicrobial biofilms in an ovine model of simulated fracture-related infection (FRI). Methods: An established model of long-bone FRI in the right hind limb of mature Rambouillet sheep was adapted. Local soft tissue trauma was induced, the periosteum was stripped from the tibial surface, and a simulated fracture was created on the bone surface. The site was inoculated with mature biofilm grown on fracture fixation plates. Sheep were assigned to a treatment group receiving 10 d of systemic antibiotic therapy or a positive control group that received no treatment. All animals were sacrificed at 21 d, and microbiological and histological analysis was performed. Results: Systemic antibiotics failed to produce a statistically significant reduction in S. aureus biofilm compared to the positive control. Systemic therapy significantly reduced P. aeruginosa bioburden compared to the positive control, but levels remained above the clinical threshold for infection. The histological analysis revealed moderate improvement from systemic treatment. Conclusions: This investigation established the limitations of systemic antibiotic therapy in this model of long-bone FRI against S. aureus and P. aeruginosa biofilms. Microbiological and histological analyses revealed hallmark features of recalcitrance to systemic treatment, validating the utility of this model to study anti-infective therapies. These findings highlight the need for new antibiotic delivery strategies to manage biofilm-associated infections.

16 September 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
DWDustin Williams
Dustin Williams
RFRobert Falconer
Robert Falconer
DRDavid L Rothberg
David L Rothberg
MLMario Lopez
Mario Lopez
JAJacob Adams
Jacob Adams
AAAshton Ashton
Ashton Ashton
Polymicrobial fracture-related infections (FRIs) underpinned by bacterial biofilms pose therapeutic challenges distinct from those of monomicrobial infection, as interspecies dynamics may alter both antimicrobial response and host tissue injury. This study evaluated systemic and local antibiotic strategies in an ovine FRI model co-inoculated with a polymicrobial Staphylococcus aureus and Pseudomonas aeruginosa biofilm. At 21 days, untreated positive controls retained substantial total bioburden yet paradoxically preserved bone volume and exhibited low osteoclast activity, contrasting with the marked osteolysis previously observed in monomicrobial infection controls using this model. Although untreated controls remained S. aureus predominant, their S. aureus:P. aeruginosa ratio declined from approximately 200:1 at inoculation to 15:1, indicating a progressive ecological shift over time. A systemic levofloxacin plus rifampin regimen more effectively reduced S. aureus than P. aeruginosa. Likewise, all antibiotic-treated groups shifted from an S. aureus-dominant inoculum toward P. aeruginosa predominance, consistent with unequal antimicrobial suppression altering polymicrobial pathogen balance. Single-dose local antibiotic powder and calcium sulfate bead strategies provided inconsistent microbiological benefit and failed to preserve bone. Reloadable local antibiotic delivery reduced S. aureus tissue bioburden and preserved the greatest bone volume among antibiotic-treated groups but the antibiotics selected for delivery did not prevent persistent P. aeruginosa colonization or the shift in pathogen balance. These findings indicate that microbiological burden reduction, residual pathogen composition, and bone preservation may result in distinct treatment outcomes in polymicrobial FRI. This study highlights the need for appropriate antibiotic selection with ecologically informed, dual targeted local and systemic strategies to manage polymicrobial, biofilm-complicated FRIs.